I don't know who it is but I bet EVG does...the s/p is getting crushed. someone has a plan and they are carrying it out...i don't know how the company can counter it except for quickly putting out future assays. Either that or acquiescing to the broker(s) with more cheap private placement shares...I posted a question to Agoracom. the question mark has been removed from my "private placement" post so someone has read it. but, it's a real shame/problem that a company with good assays is getting this treatment...Could the market also be thinking that this last assay stunk?